These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 12115617)

  • 21. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
    Scheu S; Alferink J; Pötzel T; Barchet W; Kalinke U; Pfeffer K
    J Exp Med; 2002 Jun; 195(12):1613-24. PubMed ID: 12070288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle.
    Mandik-Nayak L; Huang G; Sheehan KC; Erikson J; Chaplin DD
    J Immunol; 2001 Aug; 167(4):1920-8. PubMed ID: 11489971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
    Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
    J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of primitive stem/progenitor bone marrow cells from LT alpha-/- donors to wild-type hosts: implications for the generation of architectural events in lymphoid B cell domains.
    Mebius RE; van Tuijl S; Weissman IL; Randall TD
    J Immunol; 1998 Oct; 161(8):3836-43. PubMed ID: 9780148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.
    Koni PA; Flavell RA
    J Exp Med; 1998 Jun; 187(12):1977-83. PubMed ID: 9625757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
    Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
    Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice.
    Ryffel B; Di Padova F; Schreier MH; Le Hir M; Eugster HP; Quesniaux VF
    J Immunol; 1997 Mar; 158(5):2126-33. PubMed ID: 9036957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor receptor-1 signaling is required for differentiation of follicular dendritic cells, germinal center formation, and full antibody responses.
    Le Hir M; Bluethmann H; Kosco-Vilbois MH; Müller M; di Padova F; Moore M; Ryffel B; Eugster HP
    J Inflamm; 1995-1996; 47(1-2):76-80. PubMed ID: 8913932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues.
    Wu Q; Wang Y; Wang J; Hedgeman EO; Browning JL; Fu YX
    J Exp Med; 1999 Sep; 190(5):629-38. PubMed ID: 10477548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
    Hisada M; Yoshimoto T; Kamiya S; Magami Y; Miyaji H; Yoneto T; Tamada K; Aoki T; Koyanagi Y; Mizuguchi J
    Cancer Gene Ther; 2004 Apr; 11(4):280-8. PubMed ID: 15002032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion.
    Wang YG; Kim KD; Wang J; Yu P; Fu YX
    J Immunol; 2005 Nov; 175(10):6997-7002. PubMed ID: 16272360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis.
    Hehlgans T; Stoelcker B; Stopfer P; Müller P; Cernaianu G; Guba M; Steinbauer M; Nedospasov SA; Pfeffer K; Männel DN
    Cancer Res; 2002 Jul; 62(14):4034-40. PubMed ID: 12124338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development.
    Cuff CA; Sacca R; Ruddle NH
    J Immunol; 1999 May; 162(10):5965-72. PubMed ID: 10229834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
    Matsumoto M
    J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue.
    Körner H; Cook M; Riminton DS; Lemckert FA; Hoek RM; Ledermann B; Köntgen F; Fazekas de St Groth B; Sedgwick JD
    Eur J Immunol; 1997 Oct; 27(10):2600-9. PubMed ID: 9368616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles.
    Mortarini R; Scarito A; Nonaka D; Zanon M; Bersani I; Montaldi E; Pennacchioli E; Patuzzo R; Santinami M; Anichini A
    Cancer Res; 2005 Apr; 65(8):3428-36. PubMed ID: 15833878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD.
    Hikichi Y; Matsui H; Tsuji I; Nishi K; Yamada T; Shintani Y; Onda H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):670-7. PubMed ID: 11726199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.